# Medication Maintenance Therapy in Community Pharmacy Settings

> **NCT03766893** · EARLY_PHASE1 · COMPLETED · sponsor: **Lifespan** · enrollment: 11 (actual)

## Conditions studied

- Opioid-use Disorder

## Interventions

- **DRUG:** Buprenorphine / Naloxone Oral Product
- **DRUG:** injectable naltrexone
- **OTHER:** Pharmacy maintenance addiction care

## Key facts

- **NCT ID:** NCT03766893
- **Lead sponsor:** Lifespan
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-01
- **Primary completion:** 2018-12-31
- **Final completion:** 2018-12-31
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2019-08-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03766893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03766893, "Medication Maintenance Therapy in Community Pharmacy Settings". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03766893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*